(Q46990082)

English

Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial.

scientific article published in April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

phase II clinical trial

0 references

author name string

Ronald L Shazer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Anjali Jain

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Anna V Galkin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Nadya Cinman

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Koo N Nguyen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ronald B Natale

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Leland Green

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Leon I Bender

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Stuart Holden

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Leslie Kaplan

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

97

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

691-697

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.05974.X

21 January 2018

High-dose intravenous estrogen therapy in advanced prostatic carcinoma. Use of serum prostate-specific antigen to monitor response.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.05974.X

21 January 2018

Estrogen receptor beta in prostate cancer: brake pedal or accelerator?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.05974.X

21 January 2018

Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.05974.X

21 January 2018

Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.05974.X

21 January 2018

Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.05974.X

21 January 2018

The selective estrogen receptor modulator, raloxifene: an overview of nonclinical pharmacology and reproductive and developmental testing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.05974.X

21 January 2018

The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.05974.X

21 January 2018

Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.05974.X

21 January 2018

Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.05974.X

21 January 2018

Cell- and ligand-specific regulation of promoters containing activator protein-1 and Sp1 sites by estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.05974.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2006.05974.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16536755%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46990082&oldid=1846219531"